Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats

Berthele, 2003, [3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain, Neuroscience, 121, 629, 10.1016/S0306-4522(03)00484-6 Chiou, 2007, Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications, Curr. Drug Targets, 8, 117, 10.2174/138945007779315605 Ciccocioppo, 1999, Effect of nociceptin on alcohol intake in alcohol-preferring rats, Psychopharmacology (Berl), 141, 220, 10.1007/s002130050828 Ciccocioppo, 2000, Nociceptin/orphanin FQ and drugs of abuse, Peptides, 21, 1071, 10.1016/S0196-9781(00)00245-X Ciccocioppo, 2000, Effect of nociceptin/orphanin FQ on the rewarding properties of morphine, Eur. J. Pharmacol., 404, 153, 10.1016/S0014-2999(00)00590-2 Ciccocioppo, 2004, Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats, Psychopharmacology (Berl), 172, 170, 10.1007/s00213-003-1645-1 Devine, 1996, The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion, Brain Res., 727, 225, 10.1016/0006-8993(96)00476-3 Di Giannuario, 2000, Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats, Peptides, 21, 1125, 10.1016/S0196-9781(00)00250-3 Economidou, 2006, Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats, Peptides, 27, 3299, 10.1016/j.peptides.2006.09.007 Economidou, 2008, Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat, Biol. Psychiatry, 64, 211, 10.1016/j.biopsych.2008.02.004 Ichikawa, 2001, In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated, NeuroReport, 12, 1757, 10.1097/00001756-200106130-00048 Jenck, 2000, A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat, Proc. Natl. Acad. Sci. U.S.A., 97, 4938, 10.1073/pnas.090514397 Kawamoto, 1999, Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397), J. Med. Chem., 42, 5061, 10.1021/jm990517p Koob, 1992, Neural mechanisms of drug reinforcement, Ann.N.Y.Acad.Sci., 654, 171, 10.1111/j.1749-6632.1992.tb25966.x Kotlinska, 2002, Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference, Behav. Pharmacol., 13, 229, 10.1097/00008877-200205000-00006 Kotlinska, 2003, Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats, Eur. J. Pharmacol., 474, 233, 10.1016/S0014-2999(03)02081-8 Kuzmin, 2003, Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone, J. Pharmacol. Exp. Ther., 304, 310, 10.1124/jpet.102.041350 Kuzmin, 2007, The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking, Neuropsychopharmacology, 32, 902, 10.1038/sj.npp.1301169 Lambert, 2008, The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential, Nat. Rev. Drug Discov., 7, 694, 10.1038/nrd2572 Le Pen, 2002, The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats, NeuroReport, 13, 451, 10.1097/00001756-200203250-00018 Lutfy, 2001, Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats, Psychopharmacology (Berl), 154, 1, 10.1007/s002130000609 Marquez, 2008, The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine, Neuropharmacology, 54, 564, 10.1016/j.neuropharm.2007.11.003 Marquez, 2008, The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine, Neuropharmacology, 54, 564, 10.1016/j.neuropharm.2007.11.003 Murphy, 1999, Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis, J. Neurochem., 73, 179, 10.1046/j.1471-4159.1999.0730179.x Murphy, 1996, Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats, Neuroscience, 75, 1, 10.1016/0306-4522(96)00322-3 Murphy, 1999, Orphanin FQ/nociceptin blocks acquisition of morphine place preference, Brain Res., 832, 168, 10.1016/S0006-8993(99)01425-0 Murphy, 2004, Nociceptin/orphanin FQ modulation of rat midbrain dopamine neurons in primary culture, Neuroscience, 127, 929, 10.1016/j.neuroscience.2004.05.055 Olianas, 2008, Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum, J. Neurochem., 107, 544, 10.1111/j.1471-4159.2008.05629.x Ozaki, 2000, In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist, Eur. J. Pharmacol., 402, 45, 10.1016/S0014-2999(00)00520-3 Rover, 2000, High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor, J. Med. Chem., 43, 1329, 10.1021/jm991129q Rutten, 2009, Extinction of conditioned place preference as a more refined method to assess the rewarding efficacy of opioids, Behav. Pharmacol., 20, S78 Sakoori, 2004, Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice, Psychopharmacology (Berl), 172, 129, 10.1007/s00213-003-1643-3 Sakoori, 2008, Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses, Neuropsychopharmacology, 33, 877, 10.1038/sj.npp.1301459 Sakoori, 2008, Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice, Neurosci. Lett., 443, 108, 10.1016/j.neulet.2008.07.043 Schlicker, 2000, Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system, Peptides, 21, 1023, 10.1016/S0196-9781(00)00233-3 Shoblock, 2005, The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference, Neuropharmacology, 49, 439, 10.1016/j.neuropharm.2005.04.008 Tzschentke, 1998, Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues, Prog. Neurobiol., 56, 613, 10.1016/S0301-0082(98)00060-4 Tzschentke, 2007, Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addict. Biol., 12, 227, 10.1111/j.1369-1600.2007.00070.x Tzschentke, 2002, Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol, Neurosci. Lett., 329, 25, 10.1016/S0304-3940(02)00571-2 Wichmann, 1999, 8-acenaphthen-1-yl-1-phenyl-1, 3, 8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists, Bioorg. Med. Chem. Lett., 9, 2343, 10.1016/S0960-894X(99)00385-6 Wichmann, 2000, Synthesis of (1S, 3aS)-8-(2, 3, 3a, 4, 5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1, 3, 8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties, Eur. J. Med. Chem., 35, 839, 10.1016/S0223-5234(00)00171-9 Zaveri, 2003, Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents, Life Sci., 73, 663, 10.1016/S0024-3205(03)00387-4 Zhao, 2003, Orphanin FQ/nociceptin blocks methamphetamine place preference in rats, NeuroReport, 14, 2383, 10.1097/00001756-200312190-00019